| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,732 | 14,213 | 10,780 | 18,916 | | Cost of Revenue | 9,391 | 7,440 | 6,624 | 10,335 | | | Gross Profit | 7,341 | 6,773 | 4,156 | 8,581 | | | Operating Expenses | | Research Development | 4,870 | 4,532 | 4,776 | 6,121 | | Selling General and Administrative | 3,011 | 3,340 | 3,873 | 4,355 | | Non Recurring | 104 | 64 | 37 | 618 | | Others | 106 |
-
|
-
|
-
| | | | Total Operating Expenses | 8,091 |
-
|
-
|
-
| | | | Operating Income or Loss | (644) | (1,163) | (4,530) | (2,513) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 140 | 3,885 | 9,061 | (1,665) | | Earnings Before Interest And Taxes | (610) | 2,722 | 4,531 | (4,178) | | Interest Expense | 124 | 145 | 251 | 6 | | Income Before Tax | (734) | 2,577 | 4,280 | (4,184) | | Income Tax Expense | 156 | 358 | (1,617) | 940 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,970 | 2,219 | 5,897 | (5,124) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (890) | 2,219 | 5,897 | (5,124) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($890) | $2,219 | $5,897 | ($5,124) |
|
0.01% Nasdaq 
Income Statement
